openPR Logo
Press release

Amyotrophic Lateral Sclerosis Treatment Market is Growing at a Highest CAGR of 21.6% by 2026 With Industry Drivers, Restraints and Competitive Analysis:

02-14-2020 10:01 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Amyotrophic Lateral Sclerosis Treatment Market

Amyotrophic Lateral Sclerosis Treatment Market

Global Amyotrophic Lateral Sclerosis Treatment Market By Disease Type (Benign Focal Amyotrophy of ALS, Infantile Spinal Muscular Atrophy, Juvenile Spinal Muscular Atrophy, Kugelberg-Welander Disease, Primary Lateral Sclerosis, Progressive Bulbar Palsy, Spinal Muscular Atrophy, Upper Motor Neuron Disease, Werdnig-Hoffman Disease, Wohlfart-Disease), Drug Type (Riluzole and Edaravone (Radicava)), By Distribution Channel (Hospital Pharmacies, and Retail & Online Pharmacies), Treatment type (Chemotherapy, Stem cell therapy) End- User (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026

Request Sample of Global Amyotrophic Lateral Sclerosis Treatment Market Research Report 2020 @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-amyotrophic-lateral-sclerosis-treatment-market

Few of the major competitors currently working in the amyotrophic lateral sclerosis treatment market are Sanofi (France), Mitsubishi Tanabe Pharma Corporation (Japan), BrainStorm Cell Limited (US), ViroMed Co., Ltd (South Korea), Ionis Pharmaceuticals (US), Genervon Biopharmaceuticals, LLC (US), Biogen (US), ORPHAZYME A/S (Denmark), Orion Pharma (Finland), Kringle Pharma, Inc. (Japan), Aquestive Therapeutics (US), Apotex Inc (Canada), Bausch Health Companies Inc. (Canada), Neuralstem, Inc. (US), Implicit Bioscience (Australia), F. Hoffmann-La Roche Ltd (Switzerland), TREEWAY (Netherlands), CYTOKINETICS, INC. (US), AB Science (France), Advanz Pharmaceutical (Canada) and few among others.

Market Analysis:

Global amyotrophic lateral sclerosis treatment market is expected to rise gradually to an estimated value of USD 3.6 billion by 2026, registering a CAGR of 21.6% in the forecast period of 2019-2026 with the annual sales of USD 0.75 billion in the year of 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Market Definition:

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, also known as motor neuron disease (MND) and Lou Gehrig's disease that affects nerve cells (motor neurons) of brain, brain stem and spinal cord that controls voluntary muscles. This disease is progressive in nature.

According to Centers for Disease Control and Prevention, there were approximately 14,000 - 15,000 people in US in 2016 having ALS, almost more than half of these cases could have been avoided with the availability of proper medical treatment. This significant number is expected to act as a driver to the market growth.

Market Drivers

Increase in the treatment awareness.
Rise in incidence cases of ALS and increasing geriatric population is expected to drive the growth of the market.
Expected launch of novel medicines would drive the growth of ALS treatment market.

Market Restraints

Lack of skilled expertise in remote areas
Fewer Government initiatives taken in this direction.

Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-amyotrophic-lateral-sclerosis-treatment-market

Segmentation: Global Amyotrophic Lateral Sclerosis Treatment Market

By Disease Type

Benign Focal Amyotrophy of ALS
Infantile Spinal Muscular Atrophy
Juvenile Spinal Muscular Atrophy
Kugelberg-Welander Disease
Primary Lateral Sclerosis
Progressive Bulbar Palsy
Spinal Muscular Atrophy
Upper Motor Neuron Disease
Werdnig-Hoffman Disease
Wohlfart-Disease

By Drug Type

Riluzole
Edaravone (Radicava)
Others

By Distribution Channel

Hospital Pharmacies
Retail
Online Pharmacies

By Treatment Type

Chemotherapy
Stem cell therapy
Others

By End- User

Hospitals
Homecare
Specialty Clinics
Others

By Geography

North America
U.S.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Key Developments in the Market:

By 3rd January 2018, Sangamo Therapeutics, Inc. and Pfizer Inc. has announced a collaboration for the development of zinc finger protein transcription factors (ZFP-TFs), a gene therapy to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene. This will help in development of product portfolio for the particular therapeutic area.

On 4th December 2017, Takeda announced research collaboration with Montreal Neurological Insititute (MNI), for exploring new treatment alternatives for the treatment of indication ALS. This partnership will help the company for developing innovative product and become market leader.

Competitive Analysis:

Global amyotrophic lateral sclerosis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of amyotrophic lateral sclerosis treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global amyotrophic lateral sclerosis treatment market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-amyotrophic-lateral-sclerosis-treatment-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amyotrophic Lateral Sclerosis Treatment Market is Growing at a Highest CAGR of 21.6% by 2026 With Industry Drivers, Restraints and Competitive Analysis: here

News-ID: 1932461 • Views: 237

More Releases from Data Bridge Market Research

Coordinate Measuring Machine Market to See Major Growth by 2026 | Aberlink Ltd, …
The latest 100+ page survey report on Coordinate Measuring Machine Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that
Spend Analytics Market Know Factors Driving the Market to Record Growth with | I …
The latest 100+ page survey report on Spend Analytics Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that competitors
Big Data and Data Engineering Services Market May Set New Growth Story | Amazon …
The latest 100+ page survey report on Big Data and Data Engineering Services Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments,
Digital Audio Workstation (DAWs) Market Know Factors Driving the Market to Recor …
The latest 100+ page survey report on Digital Audio Workstation (DAWs) Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges

All 5 Releases


More Releases for Disease

Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Crohns Disease Treatment Market
Crohn’s disease is a chronic inflammatory bowel syndrome that causes inflammation in the gastrointestinal tract. Inflammation can take place anywhere between mouth to anus. It commonly affects end of small intestine (Ileum) and beginning of the colon. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, frequent diarrhea, reduced appetite, and fever. Sometimes rectal bleeding is also observed due to fissures from inflammation at anal canal.
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Peyronie’s Disease Treatment Market
Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. This condition can cause painful erections and the penis gets bent while it is erected. The bent is towards the side where plaque is being formed i.e. either downwards or upwards. The condition is identified by a major bend or pain. In a few people
Cardiovascular Disease Prevention
Reduce Your Risk of Cardiovascular Disease… Useful information about how you can lower your blood pressure, lower cholesterol, and decrease your risk of heart disease. One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the